The Trump administration's decision to cut $500 million for new vaccine development raises concerns among health care administrators at UC Davis about potential risks during future outbreaks.

People with head and neck cancer in England will be fast-tracked on to a clinical trial for a “potentially transformative” vaccine under new NHS plans.

Despite advances in care for patients with head and neck cancer, the advanced form of the disease is difficult to treat and ...

The federal government’s decision to slash $500 million in funding for mRNA vaccine research has sparked concern among health ...

GSK provides update on US settlement of CureVac/BioNTech mRNA patent litigation: London, UK Saturday, August 9, 2025, 10:00 Hrs [IST] GSK plc announces that, in connection with th ...

A long list of medical experts are saying Robert F. Kennedy Jr.'s decision to cut mRNA research will set back the country’s ...

Federal regulators are caught between old-guard conservatives who demand continued mRNA funding, Rep. Massie's demand to ...

Health Secretary Robert F. Kennedy Jr. in a statement this week announced 22 projects, totaling $500 million, to develop ...

Kennedy’s $500M cut to mRNA funding puts startups at risk and imperils one of life sciences’ few leasing bright spots.

US Health Secretary Robert F. Kennedy Jr. cited false claims to justify terminating 22 federal contracts for mRNA-based ...

Dr. Cynthia Leifer, an immunologist at Cornell University, provided her reaction on Thursday to RFK Jr.'s plan to cancel $500 million in mRNA vaccine contracts.

This week, the Trump administration announced funding cuts to mRNA vaccine development research in the US, but researchers have warned that the impacts will be felt internationally. To get a handle on ...